Lactoferrin + Vitamin E + Zinc for Hormonal Acne

Launched by UNITED LABORATORIES · Nov 28, 2021

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Females aged 22-50.
• • 2. At least 3 inflammatory acne lesions, mostly found on (but not limited to) the lower face
• • 3. Not responsive to conventional treatment
• • 4. Clinical diagnosis of mild to moderate acne according to Lehmann et. al.
• Exclusion Criteria:
• • 1. Females who are pregnant (confirmed by a pregnancy test), breast- feeding, or planning a pregnancy.
• • 2. Post-menopausal women
• • 3. Current or recent (within 3 months) use of any topical or oral anti- acne products,
• • 4. Hormonal contraceptive intake in the preceding six months
• • 5. A cancer diagnosis within the past 5 years
• • 6. History of hypersensitivity to any component of the test product.
• • 7. Current imuunosuppression. Specifically, these include patients with co-morbidities such as diabetes, HIV, chronic diseases patients requiring maintenance medications, such as vascular disease,
• • hepatitis, eczema, psoriasis, or acute febrile/infectious illnesses
• • (i.e. Dengue, pneumonia, etc)